EDIT vs NFLX · rev $32.3M vs P/E 25, rev $45.18B
Editas Medicine Inc (EDIT) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ. It is led by Ted Sarandos.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NFLX revenue for 2025-12-31 was $45.18B. Net income was $10.98B. Revenue was up 15.9% from 2024-12-31 to 2025-12-31. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
EDIT currently screens at market cap $375.2M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the EDIT and NFLX stock pages for the full models.
Not investment advice.